BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23071787)

  • 1. The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk.
    Proestling K; Hebar A; Pruckner N; Marton E; Vinatzer U; Schreiber M
    PLoS One; 2012; 7(10):e47325. PubMed ID: 23071787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.
    Tan XL; Popanda O; Ambrosone CB; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Chang-Claude J
    Breast Cancer Res Treat; 2006 Jun; 97(3):255-62. PubMed ID: 16331344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
    Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M
    BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
    Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
    Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.
    Xiang B; Mi YY; Li TF; Liu PF
    Asian Pac J Cancer Prev; 2012; 13(5):1787-91. PubMed ID: 22901123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.
    Schmidt MK; Tommiska J; Broeks A; van Leeuwen FE; Van't Veer LJ; Pharoah PD; Easton DF; Shah M; Humphreys M; Dörk T; Reincke SA; Fagerholm R; Blomqvist C; Nevanlinna H
    Breast Cancer Res; 2009; 11(6):R89. PubMed ID: 20021639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy.
    Zavarykina TM; Tyulyandina AS; Khokhlova SV; Khabas GN; Asaturova AV; Nosova YA; Brenner PK; Kapralova MA; Atkarskaya MV; Khodyrev DS; Burdennyi AM; Loginov VI; Stenina MB; Sukhikh GT
    Bull Exp Biol Med; 2020 Aug; 169(4):486-490. PubMed ID: 32910383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women.
    Jiang P; Liu J; Li W; Zeng X; Tang J
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):671-6. PubMed ID: 20732856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.
    Das M; Sharma SK; Sekhon GS; Mahanta J; Phukan RK; Jalan BK
    Tumour Biol; 2017 May; 39(5):1010428317698384. PubMed ID: 28459370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
    Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of p53 codon 72 polymorphism in patients with breast cancer.
    Vieira JO; da Silva ID; Higo PE; Nogueira-de-Souza NC; Gebrim LH
    Eur J Gynaecol Oncol; 2008; 29(4):364-7. PubMed ID: 18714570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
    Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
    Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
    Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
    Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21.
    Su L; Sai Y; Fan R; Thurston SW; Miller DP; Zhou W; Wain JC; Lynch TJ; Liu G; Christiani DC
    Lung Cancer; 2003 Jun; 40(3):259-66. PubMed ID: 12781424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility.
    Liu J; Tang X; Li M; Lu C; Shi J; Zhou L; Yuan Q; Yang M
    Breast Cancer Res Treat; 2013 Jul; 140(1):151-7. PubMed ID: 23793604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
    Ye J; Li XF; Wang YD; Yuan Y
    PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
    Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
    World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.